Meeting Videos

Examining the Impact of Real-World Evidence on Medical Product Development: Application

07/17/2018 - Session III: Critchlow (6:58 )

Speaker Presentation

07/17/2018 - Day 1 Closing
Greg Simon
Kaiser Permanente Washington Health Research Institute

Speaker Presentation

07/17/2018 - Opening Remarks: McClellan
Mark McClellan
Duke-Margolis Center for Health Policy

Speaker Presentation

07/17/2018 - Opening Remarks: Simon
Gregory Simon
Kaiser Permanente Washington Health Research Institute

Speaker Presentation

07/17/2018 - Session I: Jonsson
Pall Jonsson
National Institute for Health and Care Excellence

Speaker Presentation

07/17/2018 - Session I: Levy
Elliott Levy
Amgen Inc.

Speaker Presentation

07/17/2018 - Session I: Stem
Komathi Stem
monARC Bionetworks

Speaker Presentation

07/17/2018 - Session II: Allen
Jeff Allen
Friends of Cancer Research

Speaker Presentation

07/17/2018 - Session II: Altan
Aylin Altan
OptumLabs

Speaker Presentation

07/17/2018 - Session II: Ball
Robert Ball
U.S. Food and Drug Administration

Speaker Presentation

07/17/2018 - Session II: Foschini
Luca Foschini
Evidation Health

Speaker Presentation

07/17/2018 - Session II: Jonsson
Pall Johnson
National Institute for Health and Care Excellence

Speaker Presentation

07/17/2018 - Session II: Yaist
Brande Yaist
Eli Lilly and Company

Speaker Presentation

07/17/2018 - Session III: Critchlow
Cathy Crithlow
Amgen, Inc.

Speaker Presentation

07/17/2018 - Session III: Dreyer
Nancy Dreyer
IQVIA

Speaker Presentation

07/17/2018 - Session III: Graham
John Graham
GlaxoSmithKline

Speaker Presentation

07/17/2018 - Session III: London
Alex John London
Carnegie Mellon University

Speaker Presentation

07/17/2018 - Session III: Smith
James P. Smith
U.S. Food and Drug Administration

Speaker Presentation

07/17/2018 - Session III: Vardeny
Orly Vardeny
University of Minnesota

Speaker Presentation

07/17/2018 - Session III: Watanabe
Jonathan Watanabe
University of California San Diego

Speaker Presentation

07/17/2018 - Session IV: Alphs
Larry Alphs
Newron Pharmaceuticals

Speaker Presentation

07/17/2018 - Session IV: Graff
Jennifer Graff
National Pharmaceutical Council

Speaker Presentation

07/17/2018 - Session IV: Nowell
Benjamin Nowell
Global Healthy Living Foundation

Speaker Presentation

07/17/2018 - Session IV: Stein
Peter Stein
U.S. Food and Drug Administration

Speaker Presentation

07/18/2018 - Closing Remarks
Mark McClellan
Duke-Margolis Center for Health Policy

Speaker Presentation

07/18/2018 - Day 2 Welcome
Greg Simon
Kaiser Permanente Washington Health Research Institute

Speaker Presentation

07/18/2018 - Session V: Daniel
Greg Daniel
Duke-Margolis Center for Health Policy

Speaker Presentation

07/18/2018 - Session V: Franklin
Jessica Franklin
Harvard Medical School

Speaker Presentation

07/18/2018 - Session V: Gormley
Nicole Gormley
U.S. Food and Drug Administration

Speaker Presentation

07/18/2018 - Session V: Izurieta
Hector Izurieta
U.S. Food and Drug Administration

Speaker Presentation

07/18/2018 - Session V: Jimenez
Javier Jimenez
Sanofi

Speaker Presentation

07/18/2018 - Session V: Li
Heng Li
U.S. Food and Drug Administration

Speaker Presentation

07/18/2018 - Session V: Martin
David Martin
U.S. Food and Drug Administration

Speaker Presentation

07/18/2018 - Session V: van der Laan
Mark van der Laan
University of California Berkeley

Speaker Presentation

07/18/2018 - Session VI: Anderson
Steven Anderson
U.S. Food and Drug Administration

Speaker Presentation

07/18/2018 - Session VI: Breckenridge
Alasdair Breckenridge
University of Liverpool

Speaker Presentation

07/18/2018 - Session VI: Corrigan-Curay
Jacqueline Corrigan-Curay
U.S. Food and Drug Administration

Speaker Presentation

07/18/2018 - Session VI: Shuren
Jeff Shuren
U.S. Food and Drug Administration

Speaker Presentation